Consistent with these findings, our experimental validation in four tumor cell lines (MDA-MB-231, MCF-7, MCF-7/ADR, and SiHa) demonstrated an inverse correlation between ABCG2 levels and drug sensitivity (Figures 1C–1F and S1D). Here, ABCG2 is linked to neoplasm.